METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HÆMATOSARCOMA AND LEUKÆMIA
- 1 November 1963
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 282 (7317) , 1077-1080
- https://doi.org/10.1016/s0140-6736(63)92854-x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: The intermediate formation of hydrogen peroxideCellular and Molecular Life Sciences, 1963
- Cytological investigations with a new class of cytotoxic agents: Methylhydrazine derivativesCellular and Molecular Life Sciences, 1963
- Tumour inhibitory effects of a new class of cytotoxic agents: Methylhydrazine derivativesCellular and Molecular Life Sciences, 1963
- Methylhydrazine derivatives, a new class of cytotoxic agentsCellular and Molecular Life Sciences, 1963